| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | Jie Sun | |
| Joseph George | |||
| Jeanine D'Armiento | |||
| P2860 | cites work | Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins | Q24291557 |
| Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling | Q33253756 | ||
| Simvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension | Q34512580 | ||
| Matrix metalloproteinases in lung diseases | Q34948039 | ||
| Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia | Q35008130 | ||
| Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. | Q35044369 | ||
| Cellular and molecular pathobiology of pulmonary arterial hypertension | Q35803229 | ||
| MMP-1: the elder of the family | Q35913628 | ||
| Current insights on the pathogenesis of pulmonary arterial hypertension. | Q36240249 | ||
| Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension | Q36482251 | ||
| Molecular pathogenesis of pulmonary arterial hypertension | Q36736065 | ||
| Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells | Q36844574 | ||
| Pathobiology of pulmonary hypertension | Q37014730 | ||
| Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice | Q37100760 | ||
| Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. | Q37209074 | ||
| Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor | Q37342415 | ||
| Pulmonary arterial hypertension: need to treat | Q37347584 | ||
| Therapeutic advances in pulmonary arterial hypertension. | Q37362631 | ||
| Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension | Q38112038 | ||
| ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. | Q39946620 | ||
| Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension | Q43834290 | ||
| Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. | Q43869307 | ||
| Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease | Q45251410 | ||
| 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. | Q46128334 | ||
| Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats | Q46701382 | ||
| Pathology of pulmonary hypertension | Q56388717 | ||
| Pulmonary Arterial Hypertension | Q58485998 | ||
| Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension | Q61895228 | ||
| Fibroblast growth factor 2: from laboratory evidence to clinical application | Q80473335 | ||
| Characterisation of a rat model of pulmonary arterial hypertension | Q80834825 | ||
| Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension | Q80866556 | ||
| Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model | Q81653915 | ||
| Pulmonary arterial hypertension | Q94474054 | ||
| P5824 | is retracted by | Retraction: Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice | Q39686754 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | 83-92 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice | |
| P478 | volume | 122 |
| Q50448302 | Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension. |
| Q38149040 | Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertension. |
| Q39035506 | Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin |
| Q38004481 | Matrix metalloproteinases and their inhibitors in pulmonary hypertension |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q35019702 | Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease |
| Q38341718 | New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication |
| Q53767909 | [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications]. |
| Q39686754 | Retraction: Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice | main subject | P921 |
Search more.